Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

36081 - 36090 of 44979 results found

The use of remdesivir in patients with COVID-19

Date
Thursday, May 11, 2023 - 4:00 AM
Description
Remdesivir has appeared to be the most effective medication against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and is broadly administered to coronavirus disease 2019 (COVID-19) patients around the world. Remdesivir is

LONG COVID SYNDROME: A CASE-CONTROL STUDY

Date
Thursday, May 11, 2023 - 4:00 AM
Description
CONCLUSION: Post-COVID-19 patients have persistent symptomatology at medium-term follow-up. Higher hsCRP in cases and the positive association of hsCRP with time suggest ongoing systemic inflammation in patients persisting for months after COVID-19.

Inflammasome signaling proteins as biomarkers of COVID-19

Date
Thursday, May 11, 2023 - 4:00 AM
Description
INTRODUCTION: One of the main characteristics of COVID-19 is an exacerbated inflammatory response that results in cardiometabolic complications and dysfunction in the nervous system. Moreover, these complications may extend beyond the period of